Oncocyte: Paul Billings

Oncocyte has appointed Paul Billings as its consulting chief medical officer, a part-time role in which he will support a range of strategic and clinical goals for the company. Billings is a pioneer in genomics and precision medicine with over 40 years of experience spanning academia, government, and the biotechnology industry. He joins Oncocyte from Biological Dynamics, where he served as CEO and chairman. Prior to that he served as chief medical officer at Natera. He has also been an advisor or a physician leader with Laboratory Corporation of America, Quest Diagnostics, Life Technologies, Johnson & Johnson, and Thermo Fisher Scientific. Billings holds an MD and PhD in immunology from Harvard University, with postgraduate training at the University of Washington.